Business Today: Latest Business News, India economy News, Stock Markets, Sensex, Mutual Funds and Indian Tax
Loading...
Search

Total 34 results found. Search for [ Avigan ]

Results 1 to 21 of 34
Reuters
October 16, 2020
The company said last month a late-stage study of Avigan had shown reduced recovery times for COVID-19 patients with non-severe symptoms and it would seek to file for approval as early as this month


Reuters
September 23, 2020
Former Japanese Prime Minister Shinzo Abe had touted Avigan's potential as Japan's contribution to a global race for coronavirus treatments, aiming for domestic approval in May


BusinessToday.In
September 9, 2020
DCGI has approved Remdesivir for \"restricted emergency use\" in India for treatment of COVID-19 patients hospitalised with severe symptoms


Mansi Jaswal
August 20, 2020
A survey conducted by Max Bupa Health Insurance company found that millennials - people in the age group of 25 to 35 years - were increasingly curious to understand health coverage


BusinessToday.In
August 20, 2020
Along with the free home delivery service, Dr Reddy's also launched a helpline centre operational between 9 am to 9 pm IST, Monday through Saturday


BusinessToday.In
August 19, 2020
Dr Reddy's Avigan will come in a complete therapy pack of 122 tablets with a two-year shelf life


BusinessToday.In
July 29, 2020
Dr Reddy's Laboratories stock rose up to 7.01% to the intraday high of Rs 4,334 compared to the previous close of Rs 4,050 on BSE


Reuters
July 29, 2020
Drug, priced at Rs 59 per tablet, is approved to treat mild to moderate COVID-19 and will be available at drug stores from Wednesday, says Hetero


PTI
July 23, 2020
To be available in 200 mg tablets, the drug will be sold at a maximum retail price of Rs 59 per tablet, Brinton Pharmaceuticals said in a statement


Reuters
July 21, 2020
\"Compared to other therapies approved for emergency use in COVID-19, FabiFlu is much more economical and an effective treatment option,\" the company said in a statement to the exchanges


PTI
July 11, 2020
The approval was given after its clinical trials on COVID-19 patients in India was found satisfactory by the expert committee


BusinessToday.In
July 10, 2020
Coronavirus vaccine news update: Serum Institute of India that is producing around four vaccine candidates including the Oxford University-AstraZeneca coronavirus candidate has said that it is expected to launch a candidate by the end of six months


Reuters
July 10, 2020
Known generically as favipiravir, Avigan was developed by a subsidiary of Fujifilm and it was approved in Japan as an emergency influenza treatment in 2014


Reuters
July 2, 2020
Brazil is the only other country to report more than 50,000 new cases in one day. The United States reported at least 49,286 cases on Tuesday


BusinessToday.In
July 1, 2020
Remdesivir supply: US Department of Health and Human Services said it has secured 500,000 treatment courses of remdesivir for American hospitals through September


BusinessToday.In
July 1, 2020
Mumbai Section 144: Unless a medical emergency, all movement of one or more people in the city has been prohibited from 9pm to 5am, stated Mumbai Police


E Kumar Sharma
July 1, 2020
Avigan, an antiviral drug to fight influenza, is believed to be effective in treatment of COVID-19 patients


PTI
July 1, 2020
Fujifilm is conducting a clinical study on Avigan to treat COVID-19 patients in Japan and the United States and has been seeking to increase the drug's production by partnering with domestic and overseas companies


PB Jayakumar
June 22, 2020
Pharma major is hopeful of exporting Fabiflu after the study proves efficacy of the drug in coronavirus treatment


PB Jayakumar
New Delhi, June 20, 2020
Glenmark developed active pharmaceutical ingredient and formulation for FabiFlu through in-house R&D; DCGI allowed fasttrack trials with Phase III in limited patients; approval process is also under Emergency Use Authorisation


PAGES 1 OF 2  12